JP7498049B2 - Method for producing post-foamable composition - Google Patents
Method for producing post-foamable composition Download PDFInfo
- Publication number
- JP7498049B2 JP7498049B2 JP2020125487A JP2020125487A JP7498049B2 JP 7498049 B2 JP7498049 B2 JP 7498049B2 JP 2020125487 A JP2020125487 A JP 2020125487A JP 2020125487 A JP2020125487 A JP 2020125487A JP 7498049 B2 JP7498049 B2 JP 7498049B2
- Authority
- JP
- Japan
- Prior art keywords
- post
- foamable composition
- foaming agent
- hydrofluoroolefin
- aqueous concentrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 131
- 238000004519 manufacturing process Methods 0.000 title claims description 28
- 239000012141 concentrate Substances 0.000 claims description 53
- 239000004088 foaming agent Substances 0.000 claims description 52
- 238000009835 boiling Methods 0.000 claims description 46
- 238000010438 heat treatment Methods 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 238000004945 emulsification Methods 0.000 claims description 23
- 238000007872 degassing Methods 0.000 claims description 20
- 239000004094 surface-active agent Substances 0.000 claims description 20
- 239000000839 emulsion Substances 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 14
- 238000011049 filling Methods 0.000 claims description 13
- 238000007599 discharging Methods 0.000 claims description 10
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- -1 polyoxyethylene Polymers 0.000 description 42
- 239000003921 oil Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 239000000499 gel Substances 0.000 description 23
- 235000014113 dietary fatty acids Nutrition 0.000 description 21
- 239000000194 fatty acid Substances 0.000 description 21
- 229930195729 fatty acid Natural products 0.000 description 21
- 238000000034 method Methods 0.000 description 21
- 238000005187 foaming Methods 0.000 description 18
- 239000006260 foam Substances 0.000 description 17
- 239000007789 gas Substances 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- 229930182478 glucoside Natural products 0.000 description 16
- 150000004665 fatty acids Chemical class 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 239000004480 active ingredient Substances 0.000 description 12
- 239000000284 extract Substances 0.000 description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 10
- 229920000289 Polyquaternium Polymers 0.000 description 10
- 229920001577 copolymer Polymers 0.000 description 10
- 229930195733 hydrocarbon Natural products 0.000 description 10
- 150000002430 hydrocarbons Chemical class 0.000 description 10
- 150000002772 monosaccharides Chemical class 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 229920003169 water-soluble polymer Polymers 0.000 description 10
- 239000004215 Carbon black (E152) Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 150000008131 glucosides Chemical class 0.000 description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 230000008016 vaporization Effects 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000010696 ester oil Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 150000005215 alkyl ethers Chemical class 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 235000014593 oils and fats Nutrition 0.000 description 4
- 229940056211 paraffin Drugs 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 238000009834 vaporization Methods 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- ORUDEUCNYHCHPB-OUUBHVDSSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-tetradecoxyoxane-3,4,5-triol Chemical compound CCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ORUDEUCNYHCHPB-OUUBHVDSSA-N 0.000 description 2
- JDRSMPFHFNXQRB-IWQYDBTJSA-N (3r,4s,5s,6r)-2-decoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group CCCCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IWQYDBTJSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- CDOOAUSHHFGWSA-OWOJBTEDSA-N (e)-1,3,3,3-tetrafluoroprop-1-ene Chemical compound F\C=C\C(F)(F)F CDOOAUSHHFGWSA-OWOJBTEDSA-N 0.000 description 2
- LDTMPQQAWUMPKS-OWOJBTEDSA-N (e)-1-chloro-3,3,3-trifluoroprop-1-ene Chemical compound FC(F)(F)\C=C\Cl LDTMPQQAWUMPKS-OWOJBTEDSA-N 0.000 description 2
- CSEAZGLCWHXBDQ-UHFFFAOYSA-N 1-(3-ethyloctan-3-yloxycarbonyl)naphthalene-2-carboxylic acid Chemical compound C1=CC=C2C(C(=O)OC(CC)(CC)CCCCC)=C(C(O)=O)C=CC2=C1 CSEAZGLCWHXBDQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004604 Blowing Agent Substances 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- UUGLJVMIFJNVFH-UHFFFAOYSA-N Hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1 UUGLJVMIFJNVFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-UCORVYFPSA-N L-ribulose Chemical compound OC[C@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-UCORVYFPSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- NEOSCXSMCDEQPS-UHFFFAOYSA-N [4-(2,2-dimethylpropanoyloxymethyl)-2-ethylhexyl] 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCC(CC)CC(CC)COC(=O)C(C)(C)C NEOSCXSMCDEQPS-UHFFFAOYSA-N 0.000 description 2
- ABKPAQVSXGDAOP-UHFFFAOYSA-N [5-(2,2-dimethylpropanoyloxy)-3-methylpentyl] 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCC(C)CCOC(=O)C(C)(C)C ABKPAQVSXGDAOP-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- PKVYKIKWKPWIMO-UHFFFAOYSA-N bis(2-butyloctyl) decanedioate Chemical compound CCCCCCC(CCCC)COC(=O)CCCCCCCCC(=O)OCC(CCCC)CCCCCC PKVYKIKWKPWIMO-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940073499 decyl glucoside Drugs 0.000 description 2
- 229940031578 diisopropyl adipate Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 2
- 229940031016 ethyl linoleate Drugs 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N itaconic acid Chemical compound OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 2
- 229940048848 lauryl glucoside Drugs 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- ATCDSAIMQFVYAG-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone;sodium Chemical compound [Na].OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O ATCDSAIMQFVYAG-UHFFFAOYSA-N 0.000 description 1
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- YTLYLLTVENPWFT-UPHRSURJSA-N (Z)-3-aminoacrylic acid Chemical compound N\C=C/C(O)=O YTLYLLTVENPWFT-UPHRSURJSA-N 0.000 description 1
- LDTMPQQAWUMPKS-UPHRSURJSA-N (z)-1-chloro-3,3,3-trifluoroprop-1-ene Chemical compound FC(F)(F)\C=C/Cl LDTMPQQAWUMPKS-UPHRSURJSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JMBWBOKFMJWVCU-UHFFFAOYSA-N 1-phenylethanone;tetradecanoic acid Chemical compound CC(=O)C1=CC=CC=C1.CCCCCCCCCCCCCC(O)=O JMBWBOKFMJWVCU-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FXRLMCRCYDHQFW-UHFFFAOYSA-N 2,3,3,3-tetrafluoropropene Chemical compound FC(=C)C(F)(F)F FXRLMCRCYDHQFW-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- FZGBADVTTLOFPU-UHFFFAOYSA-N 2-(2-dodecanoyloxyethoxy)ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCCCC FZGBADVTTLOFPU-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 1
- XNKMPLWXFAJIRB-UHFFFAOYSA-N 2-[2-(16-methylheptadecanoyloxy)ethoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCCCCCCCC(C)C XNKMPLWXFAJIRB-UHFFFAOYSA-N 0.000 description 1
- RGCDGRWWIGMWER-UHFFFAOYSA-N 2-[2-(2-dodecanoyloxyethoxy)ethoxy]ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCCCCCC RGCDGRWWIGMWER-UHFFFAOYSA-N 0.000 description 1
- CJHGCXGTUHBMMH-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethyl dihydrogen phosphate Chemical compound OCCOCCOCCOP(O)(O)=O CJHGCXGTUHBMMH-UHFFFAOYSA-N 0.000 description 1
- HJRDNARELSKHEF-CLFAGFIQSA-N 2-[2-[(z)-octadec-9-enoyl]oxyethoxy]ethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOCCOC(=O)CCCCCCC\C=C/CCCCCCCC HJRDNARELSKHEF-CLFAGFIQSA-N 0.000 description 1
- ALVGIJJKUWXGCF-UHFFFAOYSA-N 2-[2-[2-(16-methylheptadecanoyloxy)ethoxy]ethoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCCCCCCCCCC(C)C ALVGIJJKUWXGCF-UHFFFAOYSA-N 0.000 description 1
- IFWVXSTYAPCLGQ-CLFAGFIQSA-N 2-[2-[2-[(Z)-octadec-9-enoyl]oxyethoxy]ethoxy]ethyl (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCC\C=C/CCCCCCCC IFWVXSTYAPCLGQ-CLFAGFIQSA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- QGLVWTFUWVTDEQ-UHFFFAOYSA-N 2-chloro-3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1Cl QGLVWTFUWVTDEQ-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- WITKSCOBOCOGSC-UHFFFAOYSA-N 2-dodecanoyloxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCCC WITKSCOBOCOGSC-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- ZVTDEEBSWIQAFJ-KHPPLWFESA-N 2-hydroxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-KHPPLWFESA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-RSVSWTKNSA-N D-altro-hexose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-RSVSWTKNSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 description 1
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 1
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- AZJUFRDUYTYIHV-NKFKGCMQSA-N Dibenzoyl Thiamine Chemical compound C=1C=CC=CC=1C(=O)OCC\C(SC(=O)C=1C=CC=CC=1)=C(/C)N(C=O)CC1=CN=C(C)N=C1N AZJUFRDUYTYIHV-NKFKGCMQSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-DHVFOXMCSA-N L-galactose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-DHVFOXMCSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WVZVXSGGSA-N L-xylulose Chemical compound OC[C@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-WVZVXSGGSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000004110 Zinc silicate Substances 0.000 description 1
- GORMSINSWZJIKL-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-dimethylpropyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC GORMSINSWZJIKL-UHFFFAOYSA-N 0.000 description 1
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 description 1
- RKFMOTBTFHXWCM-UHFFFAOYSA-M [AlH2]O Chemical compound [AlH2]O RKFMOTBTFHXWCM-UHFFFAOYSA-M 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- GZCGUPFRVQAUEE-KAZBKCHUSA-N aldehydo-D-talose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KAZBKCHUSA-N 0.000 description 1
- GZCGUPFRVQAUEE-AZGQCCRYSA-N aldehydo-L-altrose Chemical compound OC[C@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-AZGQCCRYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-YUPRTTJUSA-N aldehydo-L-lyxose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-YUPRTTJUSA-N 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- YKDMBTQVKVEMSA-UHFFFAOYSA-N diethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCCCCCCCCCC YKDMBTQVKVEMSA-UHFFFAOYSA-N 0.000 description 1
- 229940111071 diethylene glycol distearate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- HXTCWLNZDIPLCA-UHFFFAOYSA-N dodecanoic acid;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCCCCCCCCCCC(O)=O HXTCWLNZDIPLCA-UHFFFAOYSA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- RMVRNAXXHCXCLR-UHFFFAOYSA-N ethenyl 2-methylprop-2-enoate;2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical compound CC(=C)C(=O)OC=C.OCC[N+](C)(C)C#P=O RMVRNAXXHCXCLR-UHFFFAOYSA-N 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- 150000002888 oleic acid derivatives Chemical class 0.000 description 1
- 229940095127 oleth-20 Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920002851 polycationic polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940068984 polyvinyl alcohol Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- PBGQLEYZVZPUGG-UHFFFAOYSA-N prop-2-eneperoxoic acid;prop-2-enoic acid Chemical compound OC(=O)C=C.OOC(=O)C=C PBGQLEYZVZPUGG-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- SONHXMAHPHADTF-UHFFFAOYSA-M sodium;2-methylprop-2-enoate Chemical compound [Na+].CC(=C)C([O-])=O SONHXMAHPHADTF-UHFFFAOYSA-M 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000005028 tinplate Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- NMEPHPOFYLLFTK-UHFFFAOYSA-N trimethoxy(octyl)silane Chemical compound CCCCCCCC[Si](OC)(OC)OC NMEPHPOFYLLFTK-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- XSMMCTCMFDWXIX-UHFFFAOYSA-N zinc silicate Chemical compound [Zn+2].[O-][Si]([O-])=O XSMMCTCMFDWXIX-UHFFFAOYSA-N 0.000 description 1
- 235000019352 zinc silicate Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Description
本発明は、後発泡性組成物の製造方法に関する。より詳細には、本発明は、発泡剤として沸点が5~25℃であるハイドロフルオロオレフィンを含有しても、吐出時には発泡剤の発泡を抑制してゲル状に吐出することができ、吐出したゲルに指などで剪断を加えることによって発泡させることのできる後発泡性組成物を製造するための、後発泡性組成物の製造方法に関する。 The present invention relates to a method for producing a post-foamable composition. More specifically, the present invention relates to a method for producing a post-foamable composition that contains a hydrofluoroolefin having a boiling point of 5 to 25°C as a foaming agent, but can be discharged in a gel form while suppressing foaming of the foaming agent during discharge, and can be foamed by applying shear with a finger or the like to the discharged gel.
特許文献1には、エアゾール用の水性原液と低沸点溶液とをそれぞれ定量圧送手段を用いて混合手段に送り込んで混合し、混合物を容器内に充填するエアゾール製品の製造方法が開示されている。特に、特許文献1には、水性原液と低沸点溶剤とを定量圧送手段に送る前に、熱交換によって加熱あるいは沸点以下の温度に冷却することが開示されている。 Patent Document 1 discloses a method for producing an aerosol product in which an aqueous concentrate for aerosols and a low-boiling-point solution are fed into a mixing means using a constant-volume pressure delivery means, mixed, and the mixture is filled into a container. In particular, Patent Document 1 discloses that the aqueous concentrate and the low-boiling-point solvent are heated or cooled to a temperature below the boiling point by heat exchange before being fed to the constant-volume pressure delivery means.
特許文献1に記載の発明は、低沸点溶液としてイソペンタンが使用されている。イソペンタンは可燃性である。そのため、引火性を抑えるために、低沸点溶液を、燃焼性の低いハイドロフルオロオレフィンに代替することが考えられる。しかしながら、ハイドロフルオロオレフィンは、イソペンタンよりも沸点が低い。そのため、ハイドロフルオロオレフィンを含むエアゾール製品は、吐出時に気化しやすい。その結果、吐出物は、吐出時に発泡しやすく、ゲル状に吐出することが困難である。 In the invention described in Patent Document 1, isopentane is used as the low boiling point solution. Isopentane is flammable. Therefore, in order to suppress flammability, it is conceivable to replace the low boiling point solution with a hydrofluoroolefin, which is less flammable. However, hydrofluoroolefin has a lower boiling point than isopentane. Therefore, aerosol products containing hydrofluoroolefin are prone to vaporization when discharged. As a result, the discharged material is prone to foaming when discharged, making it difficult to discharge in a gel form.
本発明は、このような従来の課題に鑑みてなされたものであり、発泡剤として沸点が5~25℃であるハイドロフルオロオレフィンを含有しても、吐出時には発泡剤の発泡を抑制してゲル状に吐出することができ、吐出したゲルに指などで剪断を加えることによって発泡させることのできる後発泡性組成物を製造するための、後発泡性組成物の製造方法を提供することを目的とする。 The present invention has been made in consideration of such conventional problems, and aims to provide a method for producing a post-foamable composition that can be discharged in a gel form while suppressing foaming of the foaming agent even when it contains a hydrofluoroolefin with a boiling point of 5 to 25°C as a foaming agent, and that can be foamed by applying shear with a finger or the like to the discharged gel.
上記課題を解決する本発明には、以下の構成が主に含まれる。 The present invention, which solves the above problems, mainly includes the following configurations:
(1)水と界面活性剤とを含む水性原液と、沸点が5~25℃であるハイドロフルオロオレフィンを含む発泡剤とを含む、後発泡性組成物の製造方法であり、前記発泡剤中に溶解している空気を25℃における飽和溶解量以下に減らす脱気工程と、脱気した前記発泡剤と前記水性原液とを混合して乳化する乳化工程と、得られた乳化物を吐出容器に充填する充填工程と、を有する、後発泡性組成物の製造方法。 (1) A method for producing a post-foamable composition comprising an aqueous stock solution containing water and a surfactant, and a foaming agent containing a hydrofluoroolefin having a boiling point of 5 to 25°C, the method comprising a degassing step for reducing the amount of air dissolved in the foaming agent to the saturated solubility amount at 25°C or less, an emulsification step for mixing the degassed foaming agent with the aqueous stock solution to emulsify, and a filling step for filling the obtained emulsion into a discharge container.
このような構成によれば、脱気工程によって、沸点が5~25℃であるハイドロフルオロオレフィンに溶解していた圧縮ガス(空気)が脱気される。その結果、吐出された後発泡性組成物は、溶解していた空気を起点とする発泡が抑制されやすい。したがって、後発泡性組成物は、ゲル状に吐出され得る。ゲル状に吐出された後発泡性組成物は、指などで剪断を加えることによって容易に発泡させることができる。 According to this configuration, the compressed gas (air) dissolved in the hydrofluoroolefin having a boiling point of 5 to 25°C is degassed by the degassing process. As a result, foaming originating from the dissolved air is easily suppressed in the discharged post-foamable composition. Therefore, the post-foamable composition can be discharged in a gel state. The post-foamable composition discharged in a gel state can be easily foamed by applying shear with a finger or the like.
(2)前記脱気工程は、前記発泡剤を沸点以上に加温する加温工程を含む、(1)記載の後発泡性組成物の製造方法。 (2) The method for producing a post-foamable composition according to (1), wherein the degassing step includes a heating step of heating the foaming agent to a temperature equal to or higher than the boiling point.
このような構成によれば、後発泡性組成物の製造方法は、発泡剤中に溶解している空気の溶解量を調整しやすい。 With this configuration, the method for producing the post-foamable composition makes it easy to adjust the amount of air dissolved in the foaming agent.
(3)前記乳化工程は、前記水性原液を前記発泡剤の沸点以上に加温し、加温した前記水性原液と、加温した前記発泡剤とを混合する工程である、(2)記載の後発泡性組成物の製造方法。 (3) The method for producing a post-foamable composition according to (2), wherein the emulsification step is a step of heating the aqueous concentrate to a temperature equal to or higher than the boiling point of the foaming agent, and mixing the heated aqueous concentrate with the heated foaming agent.
このような構成によれば、乳化工程において、水性原液と発泡剤との混合物は、ゆっくりと粘度上昇する。そのため、水性原液と発泡剤とは、均一に混合されやすい。その結果、得られる後発泡性組成物は、安定して吐出されやすい。 With this configuration, the viscosity of the mixture of the aqueous concentrate and the foaming agent increases slowly during the emulsification process. Therefore, the aqueous concentrate and the foaming agent are easily mixed uniformly. As a result, the resulting post-foamable composition is easily discharged stably.
(4)前記加温工程は、前記発泡剤を収容している容器内や配管内の気体を外部に排出する排出工程を含む、(2)または(3)記載の後発泡性組成物の製造方法。 (4) The method for producing a post-foamable composition according to (2) or (3), wherein the heating step includes a discharging step of discharging gas from the container or piping that contains the foaming agent to the outside.
このような構成によれば、排出工程において、発泡剤に溶解していた空気が外部に排出され得る。これにより、発泡剤への空気の再溶解を防ぐことができる。その結果、得られる後発泡性組成物は、吐出時の発泡を抑制しやすく、ゲル状に吐出されやすい。 With this configuration, the air dissolved in the foaming agent can be discharged to the outside during the discharging process. This makes it possible to prevent the air from redissolving in the foaming agent. As a result, the resulting post-foamable composition is more likely to suppress foaming during discharge and is more likely to be discharged in a gel-like form.
(5)前記乳化工程は、30~80℃で、前記水性原液と前記発泡剤とを乳化する工程である、(1)~(4)のいずれかに記載の後発泡性組成物の製造方法。 (5) The method for producing a post-foamable composition according to any one of (1) to (4), wherein the emulsification step is a step of emulsifying the aqueous concentrate and the foaming agent at 30 to 80°C.
このような構成によれば、乳化工程において、水性原液と発泡剤との混合物の粘度が上昇しにくい。そのため、混合物の温度を維持しやすく、吐出容器に充填しやすい。充填された混合物(後発泡性組成物)は、その後、粘度上昇しやすい。 With this configuration, the viscosity of the mixture of the aqueous concentrate and the foaming agent is less likely to increase during the emulsification process. This makes it easier to maintain the temperature of the mixture and to fill it into the discharge container. The viscosity of the filled mixture (post-foamable composition) is then likely to increase.
本発明によれば、発泡剤として沸点が5~25℃であるハイドロフルオロオレフィンを含有しても、吐出時には発泡剤の発泡を抑制してゲル状に吐出することができ、吐出したゲルに指などで剪断を加えることによって発泡させることのできる後発泡性組成物を製造するための、後発泡性組成物の製造方法を提供することができる。 According to the present invention, even if a hydrofluoroolefin having a boiling point of 5 to 25°C is used as a foaming agent, the foaming of the foaming agent can be suppressed during extrusion, and the composition can be extruded in a gel form, and the extruded gel can be foamed by applying shear with a finger or the like. This provides a method for producing a post-foamable composition.
<後発泡性組成物および後発泡性組成物の製造方法>
本発明の一実施形態の後発泡性組成物の製造方法は、水と界面活性剤とを含む水性原液と、沸点が5~25℃であるハイドロフルオロオレフィンを含む発泡剤とを含む、後発泡性組成物の製造方法である。後発泡性組成物の製造方法は、発泡剤中に溶解している空気を25℃における飽和溶解量以下に減らす脱気工程と、脱気した発泡剤と水性原液とを混合して乳化する乳化工程と、得られた乳化物を吐出容器に充填する充填工程と、を有する。以下、それぞれについて説明する。なお、以下の説明では、説明の明瞭化のため、目的物である後発泡性組成物を先に説明する。
<Post-foamable composition and method for producing post-foamable composition>
The method for producing a post-foamable composition according to one embodiment of the present invention is a method for producing a post-foamable composition comprising an aqueous concentrate containing water and a surfactant, and a foaming agent containing a hydrofluoroolefin having a boiling point of 5 to 25° C. The method for producing a post-foamable composition includes a degassing step for reducing the amount of air dissolved in the foaming agent to a saturated solubility amount or less at 25° C., an emulsification step for mixing the degassed foaming agent and the aqueous concentrate to emulsify, and a filling step for filling a discharge container with the obtained emulsion. Each step will be described below. In the following description, the post-foamable composition, which is the target product, will be described first for clarity.
本実施形態の後発泡性組成物は、水と界面活性剤とを含む水性原液と、沸点が5~25℃であるハイドロフルオロオレフィンを含む発泡剤とを含む。 The post-foamable composition of this embodiment contains an aqueous concentrate containing water and a surfactant, and a foaming agent containing a hydrofluoroolefin having a boiling point of 5 to 25°C.
(水性原液)
水性原液は、水と界面活性剤を含む。
(Aqueous stock solution)
The aqueous concentrate contains water and a surfactant.
・水
水は、水性原液の主溶媒として用いられる。水が含まれることにより、水性原液は、沸点が5~25℃であるハイドロフルオロオレフィンを含む発泡剤と乳化して安定な後発泡性組成物となる。後発泡性組成物は、吐出時はゲル状物となり、ゲル状物はその後徐々に発泡して、または、ゲル状物に指などでせん断を加えると発泡してフォームを形成することができ、顔、頭髪、腕、手、脚等の適用箇所において塗り拡げやすい。
Water: Water is used as the main solvent of the aqueous concentrate. By including water, the aqueous concentrate is emulsified with a foaming agent containing a hydrofluoroolefin having a boiling point of 5 to 25°C to form a stable post-foamable composition. The post-foamable composition becomes a gel-like substance when discharged, and the gel-like substance gradually foams thereafter, or foams when sheared with a finger or the like to form a foam, which is easy to apply and spread on application sites such as the face, hair, arms, hands, and legs.
水は特に限定されない。一例を挙げると、水は、精製水、イオン交換水、生理食塩水、海洋深層水等である。 The water is not particularly limited. Examples of the water include purified water, ion-exchanged water, saline solution, deep sea water, etc.
水の含有量は、特に限定されない。一例を挙げると、水は、後発泡性組成物中、30質量%以上であることが好ましく、40質量%以上であることがより好ましい。また、水は、後発泡性組成物中、90質量%以下であることが好ましく、80質量%以下であることがより好ましい。水の含有量が上記範囲内であることにより、水性原液はハイドロフルオロオレフィンを含む発泡剤と乳化して安定な後発泡性組成物となり、吐出時はゲル状となり、その後発泡してフォームを形成しやすい。 The water content is not particularly limited. For example, the water content in the post-foamable composition is preferably 30% by mass or more, more preferably 40% by mass or more. The water content in the post-foamable composition is preferably 90% by mass or less, more preferably 80% by mass or less. When the water content is within the above range, the aqueous concentrate is emulsified with the foaming agent containing hydrofluoroolefin to form a stable post-foamable composition, which becomes gel-like when discharged and then easily foams to form a foam.
・界面活性剤
界面活性剤は、水性原液とハイドロフルオロオレフィンとを乳化させて安定な後発泡性組成物を形成するために配合される。また、界面活性剤は、吐出時はハイドロフルオロオレフィンを安定に保持してゲル状とし、ハイドロフルオロオレフィンの気化により水性原液を発泡させてフォームを形成する等の目的で配合される。
Surfactant The surfactant is blended to emulsify the aqueous concentrate and the hydrofluoroolefin to form a stable post-foamable composition. The surfactant is also blended for the purposes of stably holding the hydrofluoroolefin in a gel state during discharge and foaming the aqueous concentrate by vaporizing the hydrofluoroolefin to form a foam, etc.
界面活性剤は特に限定されない。一例を挙げると、界面活性剤は、脂肪酸石鹸、アルキル硫酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、アルキルリン酸塩、ポリオキシエチレンアルキルエーテルリン酸塩などの陰イオン性界面活性剤;ポリオキシエチレンアルキルエーテル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルエーテル脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステルなどの非イオン性界面活性剤:(アクリル酸/イタコン酸ステアレス)コポリマー、(アクリル酸/イタコン酸セテス)コポリマー、アクリル酸/アミノアクリレート/C10-30アルキルPEG-20イタコン酸)コポリマーなどの会合型増粘剤;アルキルアンモニウム塩、ポリオキシエチレンアルキルアミンなどの陽イオン型界面活性剤;アルキルベタイン、脂肪酸アミドプロピルベタインなどの両性界面活性剤;シリコーン系界面活性剤;N-アシルグルタミン酸塩、N-アシルグルタミン酸、N-アシルグリシン塩、N-アシルアラニン塩などのアミノ酸系界面活性剤等である。界面活性剤は、併用されてもよい。 The surfactant is not particularly limited. Examples of the surfactant include anionic surfactants such as fatty acid soap, alkyl sulfate, polyoxyethylene alkyl ether sulfate, alkyl phosphate, and polyoxyethylene alkyl ether phosphate; polyoxyethylene alkyl ether, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene polyoxypropylene alkyl ether, polyethylene glycol fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether fatty acid ester, polyoxyethylene sorbitan fatty acid ester, and polyoxyethylene sorbitan fatty acid ester. nonionic surfactants such as fatty acid esters; associative thickeners such as (acrylic acid/steareth itaconate) copolymer, (acrylic acid/ceteth itaconate) copolymer, and acrylic acid/aminoacrylate/C10-30 alkyl PEG-20 itaconate copolymer; cationic surfactants such as alkyl ammonium salts and polyoxyethylene alkylamines; amphoteric surfactants such as alkyl betaines and fatty acid amidopropyl betaines; silicone surfactants; amino acid surfactants such as N-acyl glutamate, N-acyl glutamic acid, N-acyl glycine salts, and N-acylalanine salts. Surfactants may be used in combination.
これらの中でも、界面活性剤は、水性原液とハイドロフルオロオレフィンとを乳化する乳化工程においてゆっくりと粘度上昇して均一な組成を形成しやすくする、後発泡性組成物を吐出容器に充填しやすくする、吐出容器に充填された後で粘度上昇して安定な後発泡性組成物となりゲル状に吐出しやすい点から、脂肪酸石鹸、ポリオキシエチレンアルキルエーテルであることが好ましく、脂肪酸石鹸であることがより好ましい。脂肪酸石鹸は、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸等を含む脂肪酸とアルカリの鹸化物であることが好ましく、ミリスチン酸、パルミチン酸とトリエタノールアミン、ジイソプロパノールアミンなどの有機アミンや水酸化ナトリウム、水酸化カリウムなどの無機アルカリの鹸化物であることがより好ましい。また、ポリオキシエチレンアルキルエーテルは、後発泡性組成物の発泡性が優れ、キメ細かい泡を形成しやすい点と、後述する固形油を含有して、吐出直後の発泡を抑制し、ゲル状に吐出しやすくした際に固形油の析出を防止できる点から、HLB値が10以上であるものを用いることが好ましい。 Among these, the surfactant is preferably a fatty acid soap or a polyoxyethylene alkyl ether, from the viewpoints that the viscosity slowly increases in the emulsification process in which the aqueous concentrate and the hydrofluoroolefin are emulsified, making it easier to form a uniform composition, making it easier to fill the post-foamable composition into a discharge container, and the viscosity increases after filling into the discharge container to form a stable post-foamable composition that is easy to discharge in a gel-like form, and fatty acid soap is more preferable. The fatty acid soap is preferably a saponification product of a fatty acid containing lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, etc. and an alkali, and more preferably a saponification product of myristic acid, palmitic acid, and an organic amine such as triethanolamine or diisopropanolamine, or an inorganic alkali such as sodium hydroxide or potassium hydroxide. In addition, it is preferable to use a polyoxyethylene alkyl ether having an HLB value of 10 or more, from the viewpoints that the post-foamable composition has excellent foamability and is easy to form fine bubbles, and that it contains a solid oil described later, suppresses foaming immediately after discharge, and prevents precipitation of the solid oil when it is easy to discharge in a gel-like form.
界面活性剤の含有量は特に限定されない。一例を挙げると、界面活性剤の含有量は、後発泡性組成物中、3質量%以上であることが好ましく、5質量%以上であることがより好ましい。また、界面活性剤の含有量は、後発泡性組成物中、30質量%以下であることが好ましく、25質量%以下であることがより好ましい。界面活性剤の含有量が上記範囲内であることにより、乳化工程において乳化物はゆっくりと粘度上昇して均一な組成を形成しやすく、吐出容器への充填が容易になる。 The surfactant content is not particularly limited. For example, the surfactant content in the post-foamable composition is preferably 3% by mass or more, and more preferably 5% by mass or more. The surfactant content in the post-foamable composition is preferably 30% by mass or less, and more preferably 25% by mass or less. When the surfactant content is within the above range, the viscosity of the emulsion increases slowly in the emulsification process, making it easier to form a uniform composition, and easier to fill the discharge container.
・任意成分
後発泡性組成物は、上記水、界面活性剤のほかに、適宜、有効成分、油剤、アルコール、単糖類、水溶性高分子、パウダー等の任意成分を含んでもよい。
Optional Components In addition to the water and surfactant described above, the post-foamable composition may contain optional components such as active ingredients, oils, alcohols, monosaccharides, water-soluble polymers, powders, etc., as appropriate.
有効成分は、製品の用途や目的などに応じて適宜選択することができる。一例を挙げると、有効成分は、天然香料、合成香料などの各種香料;ジアルキルアミノアルキル(メタ)アクリレート-(メタ)アクリル酸アルキルエステル共重合体、アクリル酸アルキルアミド-アクリル酸ヒドロキシアルキル-メタクリル酸アルキルアミノアルキル共重合体などの両性型樹脂、およびたとえばアクリル酸アルキル共重合体エマルジョン、アクリル酸アルキル-スチレン共重合体エマルジョン、ビニルピロリドン-スチレン共重合体エマルジョン、アクリル酸-アクリル酸ヒドロキシエステル共重合体エマルジョンなどのエマルジョン系樹脂などのスタイリング剤;l-メントール、カンフル、ハッカ油などの清涼剤;レチノール、酢酸レチノール、パルミチン酸レチノール、パントテン酸カルシウム、アスコルビン酸リン酸マグネシウム、アスコルビン酸ナトリウム、dl-α-トコフェロール、酢酸トコフェロール、トコフェロール、ニコチン酸トコフェロール、ジベンゾイルチアミン、リボフラビンおよびこれらの混合物などのビタミン類;アスコルビン酸、α-トコフェロール、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソールなどの酸化防止剤;グリシン、アラニン、ロイシン、セリン、トリプトファン、システイン、メチオニン、アスパラギン酸、グルタミン酸、アルギニンなどのアミノ酸;コラーゲン、ヒアルロン酸、カロニン酸、乳酸ナトリウム、dl-ピロリドンカルボン酸塩、ケラチン、カゼイン、レシチン、尿素などの保湿剤;パラオキシ安息香酸エステル、安息香酸ナトリウム、ソルビン酸カリウム、フェノキシエタノールなどの防腐剤;塩化ベンザルコニウム、塩化ベンゼトニウム、塩化クロルヘキシジン、パラクロルメタクレゾールなどの殺菌消毒剤;ローヤルゼリーエキス、シャクヤクエキス、ヘチマエキス、バラエキス、レモンエキス、アロエエキス、ショウブ根エキス、ユーカリエキス、セージエキス、茶エキス、海藻エキス、プラセンタエキス、シルク抽出液などの抽出液;酸化亜鉛、アラントインヒドロキシアルミニウム、タンニン酸、クエン酸、乳酸などの収斂剤;アラントイン、グリシルレチン酸、グリチルリチン酸ジカリウム、アズレンなどの抗炎症剤;ラウリル酸メタクリレート、安息香酸メチル、フェニル酢酸メチル、ゲラニルクロトレート、ミリスチン酸アセトフェノン、酢酸ベンジル、プロピオン酸ベンジル、緑茶エキスなどの消臭剤;ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、パラメトキシケイ皮酸2-エチルヘキシル、エチルヘキシルトリアゾン、オキシベンゾン、ヒドロキシベンゾフェノンスルホン酸、ジヒドロキシベンゾフェノンスルホン酸ナトリウム、ジヒドロキシベンゾフェノンなどの紫外線吸収剤;酸化亜鉛、酸化チタン、オクチルトリメトキシシラン被覆酸化チタンなどの紫外線散乱剤;アルブチン、コウジ酸などの美白剤;クロロヒドロキシアルミニウム、イソプロピルメチルフェノールなどの制汗剤;サリチル酸メチル、インドメタシン、フェルビナク、ケトプロフェンなどの消炎鎮痛剤等である。 The active ingredient can be appropriately selected depending on the application and purpose of the product. For example, the active ingredient may be various fragrances such as natural fragrances and synthetic fragrances; styling agents such as amphoteric resins such as dialkylaminoalkyl (meth)acrylate-(meth)acrylic acid alkyl ester copolymers, alkyl acrylate amide-hydroxyalkyl acrylate-alkylaminoalkyl methacrylate copolymers, and emulsion resins such as alkyl acrylate copolymer emulsions, alkyl acrylate-styrene copolymer emulsions, vinylpyrrolidone-styrene copolymer emulsions, and acrylic acid-hydroxyester acrylic acid copolymer emulsions; cooling agents such as l-menthol, camphor, and peppermint oil; retinol, retinol acetate, retinol palmitate, pantothenic acid, and the like. vitamins such as calcium ascorbate, magnesium ascorbyl phosphate, sodium ascorbate, dl-α-tocopherol, tocopherol acetate, tocopherol, tocopherol nicotinate, dibenzoylthiamine, riboflavin and mixtures thereof; antioxidants such as ascorbic acid, α-tocopherol, dibutylhydroxytoluene, butylhydroxyanisole; amino acids such as glycine, alanine, leucine, serine, tryptophan, cysteine, methionine, aspartic acid, glutamic acid, arginine; moisturizers such as collagen, hyaluronic acid, caronic acid, sodium lactate, dl-pyrrolidone carboxylate, keratin, casein, lecithin, urea, etc.; paraoxybenzoic acid esters, Preservatives such as sodium benzoate, potassium sorbate, and phenoxyethanol; bactericidal disinfectants such as benzalkonium chloride, benzethonium chloride, chlorhexidine chloride, and parachlormetacresol; extracts such as royal jelly extract, peony extract, loofah extract, rose extract, lemon extract, aloe extract, calamus root extract, eucalyptus extract, sage extract, tea extract, seaweed extract, placenta extract, and silk extract; astringents such as zinc oxide, allantoin hydroxyaluminum, tannic acid, citric acid, and lactic acid; anti-inflammatory agents such as allantoin, glycyrrhetinic acid, dipotassium glycyrrhizinate, and azulene; methacrylate laurate, methyl benzoate, methyl phenylacetate, and geranyl clotreol. deodorants such as hexyl benzoate, acetophenone myristate, benzyl acetate, benzyl propionate, and green tea extract; ultraviolet absorbers such as diethylaminohydroxybenzoylhexyl benzoate, 2-ethylhexyl paramethoxycinnamate, ethylhexyl triazone, oxybenzone, hydroxybenzophenone sulfonic acid, dihydroxybenzophenone sodium sulfonate, and dihydroxybenzophenone; ultraviolet scattering agents such as zinc oxide, titanium oxide, and octyltrimethoxysilane-coated titanium oxide; whitening agents such as arbutin and kojic acid; antiperspirants such as chlorohydroxyaluminum and isopropylmethylphenol; and anti-inflammatory analgesics such as methyl salicylate, indomethacin, felbinac, and ketoprofen.
有効成分が配合される場合、有効成分の含有量は特に限定されない。一例を挙げると、有効成分の含有量は、後発泡性組成物中、0.1質量%以上であることが好ましく、0.3質量%以上であることがより好ましい。また、有効成分の含有量は、後発泡性組成物中、20質量%以下であることが好ましく、15質量%以下であることがより好ましい。有効成分の含有量が上記範囲内であることにより、有効成分を配合することによる効果が得られやすく、かつ、後発泡性組成物は、有効成分によって発泡性が低下しにくい。 When an active ingredient is blended, the content of the active ingredient is not particularly limited. For example, the content of the active ingredient in the post-foamable composition is preferably 0.1% by mass or more, and more preferably 0.3% by mass or more. The content of the active ingredient in the post-foamable composition is preferably 20% by mass or less, and more preferably 15% by mass or less. By having the content of the active ingredient within the above range, the effect of blending the active ingredient is easily obtained, and the foamability of the post-foamable composition is less likely to be reduced by the active ingredient.
・油剤
油剤は、水性原液とハイドロフルオロオレフィンとを乳化する工程において、ゆっくりと粘度上昇して均一な組成を形成しやすくする、乳化物を充填しやすくする等の目的で配合される。また、油剤は、吐出時のハイドロフルオロオレフィンの気化を抑えてゲル状に吐出しやすくする等の目的で配合される。
Oil agents are blended in the process of emulsifying the aqueous concentrate and the hydrofluoroolefin for the purposes of slowly increasing the viscosity to facilitate the formation of a uniform composition, making it easier to fill the emulsion, etc. In addition, oil agents are blended in for the purposes of suppressing the evaporation of the hydrofluoroolefin during discharge to facilitate discharging it in a gel state, etc.
油剤は特に限定されない。一例を挙げると、油剤は、エステル油、炭化水素油、油脂、シリコーンオイル、液状の高級脂肪酸、液状の高級アルコール、固形の炭化水素、固形の高級脂肪酸、固形の高級アルコール、アルキルグルコシド等である。これらは併用されてもよい。 The oil is not particularly limited. Examples of the oil include ester oil, hydrocarbon oil, oils and fats, silicone oil, liquid higher fatty acids, liquid higher alcohols, solid hydrocarbons, solid higher fatty acids, solid higher alcohols, and alkyl glucosides. These may be used in combination.
なお、乳化工程においてゆっくりと粘度上昇して均一な組成を形成しやすくする、乳化物を充填しやすくするために、また、吐出時においてハイドロフルオロオレフィンの気化を抑制し、ゲル状に吐出しやすくするために、エステル油、炭化水素油、油脂、シリコーンオイル、液状の高級脂肪酸、液状の高級アルコール等の25℃において液状である液状油が配合されることが好ましい。 In addition, in order to make it easier to form a uniform composition by slowly increasing the viscosity during the emulsification process and to make it easier to fill the emulsion, and also to suppress the evaporation of the hydrofluoroolefin during discharge and make it easier to discharge in a gel state, it is preferable to add a liquid oil that is liquid at 25°C, such as ester oil, hydrocarbon oil, oils and fats, silicone oil, liquid higher fatty acids, and liquid higher alcohols.
エステル油は特に限定されない。一例を挙げると、エステル油は、ジネオペンタン酸メチルペンタンジオール、ジネオペンタン酸ジエチルペンタンジオール、セバシン酸ジエチル、アジピン酸ジイソプロピル、ナフタリンジカルボン酸ジエチルヘキシル、セバシン酸ジブチルオクチル、ジ-2-エチルへキサン酸ネオペンチルグリコール、ジカプリン酸ネオペンチルグリコール、ジラウリン酸プロピレングリコール、ジステアリン酸エチレングリコール、ジラウリン酸ジエチレングリコール、ジステアリン酸ジエチレングリコール、ジイソステアリン酸ジエチレングリコール、ジオレイン酸ジエチレングリコール、ジラウリン酸トリエチレングリコール、ジステアリン酸トリエチレングリコール、ジイソステアリン酸トリエチレングリコール、ジオレイン酸トリエチレングリコール、モノステアリン酸プロピレングリコール、モノオレイン酸プロピレングリコール、モノステアリン酸エチレングリコール、トリ2-エチルへキサン酸グリセリル、トリ(カプリル・カプリン酸)グリセリン、イソノナン酸イソノニル、イソノナン酸イソトリデシル、コハク酸ジエトキシエチル、リンゴ酸ジイソステアリル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、リノール酸エチル、イソオクタン酸セチル、ヒドロキシステアリン酸オクチル、ヒドロシキシステアリン酸エチルヘキシル等である。これらの中でも、エステル油は、水性原液とハイドロフルオロオレフィンとを乳化して均一相を形成しやすい点から、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、リノール酸エチル等の直鎖脂肪酸と低級アルコールとのエステル;ジネオペンタン酸メチルペンタンジオール、ジネオペンタン酸ジエチルペンタンジオール、セバシン酸ジエチル、アジピン酸ジイソプロピル、ナフタリンジカルボン酸ジエチルヘキシル、セバシン酸ジブチルオクチル等の多塩基酸エステル等であることがより好ましい。 The ester oil is not particularly limited. Examples of the ester oil include methyl pentanediol dineopentanoate, diethyl pentanediol dineopentanoate, diethyl sebacate, diisopropyl adipate, diethylhexyl naphthalene dicarboxylate, dibutyl octyl sebacate, neopentyl glycol di-2-ethylhexanoate, neopentyl glycol dicaprate, propylene glycol dilaurate, ethylene glycol distearate, diethylene glycol dilaurate, diethylene glycol distearate, diethylene glycol diisostearate, diethylene glycol dioleate, triethylene glycol dilaurate, distearate, Examples of suitable oleic acid salts include triethylene glycol phosphate, triethylene glycol diisostearate, triethylene glycol dioleate, propylene glycol monostearate, propylene glycol monooleate, ethylene glycol monostearate, glyceryl tri-2-ethylhexanoate, tri(caprylic/capric acid)glycerin, isononyl isononanoate, isotridecyl isononanoate, diethoxyethyl succinate, diisostearyl malate, isopropyl myristate, isopropyl palmitate, ethyl linoleate, cetyl isooctanoate, octyl hydroxystearate, and ethylhexyl hydroxystearate. Among these, the ester oil is preferably an ester of a straight-chain fatty acid and a lower alcohol, such as isopropyl myristate, isopropyl palmitate, or ethyl linoleate, or a polybasic acid ester, such as methyl pentanediol dineopentanoate, diethyl pentanediol dineopentanoate, diethyl sebacate, diisopropyl adipate, diethylhexyl naphthalene dicarboxylate, or dibutyl octyl sebacate, because it is easy to emulsify the aqueous concentrate and the hydrofluoroolefin to form a homogeneous phase.
炭化水素油は特に限定されない。一例を挙げると、炭化水素油は、流動パラフィン、ケロシン、スクワレン、スクワラン、イソパラフィン等である。これらの中でも、炭化水素油は、水性原液とハイドロフルオロオレフィンとを乳化して均一な組成を形成しやすい点から、流動パラフィン等であることが好ましい。 The hydrocarbon oil is not particularly limited. Examples of the hydrocarbon oil include liquid paraffin, kerosene, squalene, squalane, and isoparaffin. Among these, the hydrocarbon oil is preferably liquid paraffin, etc., because it is easy to emulsify the aqueous concentrate and the hydrofluoroolefin to form a uniform composition.
油脂は特に限定されない。一例を挙げると、油脂は、アボカド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、アマニ油、サフラワー油、ホホバ油、麦芽油、ヤシ油、パーム油等である。 The oils and fats are not particularly limited. Examples of the oils and fats include avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, sesame oil, castor oil, linseed oil, safflower oil, jojoba oil, malt oil, coconut oil, palm oil, etc.
シリコーンオイルは特に限定されない。一例を挙げると、シリコーンオイルは、メチルポリシロキサン、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン、メチルポリシクロシロキサン等である。 The silicone oil is not particularly limited. Examples of the silicone oil include methyl polysiloxane, methyl phenyl polysiloxane, methyl hydrogen polysiloxane, methyl polycyclo siloxane, etc.
液状の高級脂肪酸は特に限定されない。一例を挙げると、液状の高級脂肪酸は、オレイン酸、イソステアリン酸、リノール酸、リノレイン酸等である。 The liquid higher fatty acid is not particularly limited. Examples of liquid higher fatty acids include oleic acid, isostearic acid, linoleic acid, and linolenic acid.
液状の高級アルコールは特に限定されない。一例を挙げると、液状の高級アルコールは、オレイルアルコール、イソステアリルアルコール等である。 The liquid higher alcohol is not particularly limited. Examples of liquid higher alcohols include oleyl alcohol and isostearyl alcohol.
また、吐出容器に充填した後の後発泡性組成物の粘度を高くして、吐出時にハイドロフルオロオレフィンの気化をより抑制するために、固形の炭化水素、固形の高級脂肪酸、固形の高級アルコール、アルキルグルコシド等の25℃において固形である固形油が配合されることが好ましい。固形油が用いられる場合、固形油は、液状油に溶解させて液状にしてから用いられることが好ましい。 In addition, in order to increase the viscosity of the post-foamable composition after it has been filled into the discharge container and to further suppress the evaporation of the hydrofluoroolefin during discharge, it is preferable to blend a solid oil that is solid at 25°C, such as a solid hydrocarbon, a solid higher fatty acid, a solid higher alcohol, or an alkyl glucoside. When a solid oil is used, it is preferable to dissolve the solid oil in a liquid oil to make it liquid before use.
固形の炭化水素は特に限定されない。一例を挙げると、固形の炭化水素は、パラフィン、ミツロウ、ラノリン、カンデリラロウ、カルナウバロウ等である。これらの中でも、固形の炭化水素は、液状油と調製しやすく、取り扱いやすい点から、パラフィン等であることが好ましい。 The solid hydrocarbon is not particularly limited. Examples of solid hydrocarbons include paraffin, beeswax, lanolin, candelilla wax, carnauba wax, etc. Among these, paraffin is preferable as the solid hydrocarbon because it can be easily prepared into a liquid oil and is easy to handle.
固形の高級脂肪酸は特に限定されない。一例を挙げると、高級脂肪酸は、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸等である。 The solid higher fatty acid is not particularly limited. Examples of higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, and behenic acid.
固形の高級アルコールは特に限定されない。一例を挙げると、高級アルコールは、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコールなどの直鎖アルコール、ラノリンアルコール、ヘキシルドデカノール、セトステアリルアルコール、オクチルドデカノールなどの分枝鎖アルコール等である。 The solid higher alcohol is not particularly limited. For example, the higher alcohol may be a straight-chain alcohol such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, or myristyl alcohol, or a branched-chain alcohol such as lanolin alcohol, hexyldodecanol, cetostearyl alcohol, or octyldodecanol.
アルキルグルコシドは特に限定されない。一例を挙げると、アルキルグルコシドは、セテアリルグルコシド、デシルグルコシド、ラウリルグルコシド、ミリスチルグルコシド、アルキル(C8-16)グルコシド、アルキル(C12-20)グルコシド、アラキルグルコシド、ヤシ油グルコシド、POEメチルグルコシド、POEジオレイン酸メチルグルコシド等である。アルキルグルコシドは、併用されてもよい。これらの中でも、アルキルグルコシドは、水性原液とハイドロフルオロオレフィンとを乳化して均一相を形成しやすい点から、セテアリルグルコシド、デシルグルコシド、ラウリルグルコシド、ミリスチルグルコシド、アルキル(C8-16)グルコシド、アルキル(C12-20)グルコシド、アラキルグルコシド、ヤシ油グルコシド等であることが好ましく、ヤシ油グルコシドであることがより好ましい。 The alkyl glucoside is not particularly limited. Examples of the alkyl glucoside include cetearyl glucoside, decyl glucoside, lauryl glucoside, myristyl glucoside, alkyl (C8-16) glucoside, alkyl (C12-20) glucoside, arachyl glucoside, coconut oil glucoside, POE methyl glucoside, and POE methyl dioleate glucoside. The alkyl glucoside may be used in combination. Among these, the alkyl glucoside is preferably cetearyl glucoside, decyl glucoside, lauryl glucoside, myristyl glucoside, alkyl (C8-16) glucoside, alkyl (C12-20) glucoside, arachyl glucoside, coconut oil glucoside, and the like, and more preferably coconut oil glucoside, in view of the ease of emulsifying the aqueous concentrate and the hydrofluoroolefin to form a uniform phase.
油剤が配合される場合、油剤の含有量は特に限定されない。一例を挙げると、油剤の含有量は、後発泡性組成物中、0.1質量%以上であることが好ましく、0.5質量%以上であることがより好ましい。また、油剤の含有量は、後発泡性組成物中、10質量%以下であることが好ましく、8質量%以下であることがより好ましい。油剤の含有量が上記範囲内であることにより、乳化工程において、ゆっくりと粘度上昇して均一な組成を形成しやすく、乳化物を充填しやすくなる。また、吐出時のハイドロフルオロオレフィンの気化を抑えてゲル状に吐出しやすくなる。 When an oil is added, the content of the oil is not particularly limited. For example, the content of the oil in the post-foamable composition is preferably 0.1% by mass or more, and more preferably 0.5% by mass or more. The content of the oil in the post-foamable composition is preferably 10% by mass or less, and more preferably 8% by mass or less. When the content of the oil is within the above range, the viscosity increases slowly in the emulsification process, making it easier to form a uniform composition and to fill the emulsion. In addition, evaporation of the hydrofluoroolefin during discharge is suppressed, making it easier to discharge in a gel state.
アルコールは、水に溶解しにくい有効成分の溶媒として好適に配合される。また、アルコールは、発泡性を調整する等の目的で好適に配合される。 Alcohol is preferably used as a solvent for active ingredients that are poorly soluble in water. It is also preferably used for purposes such as adjusting the foaming properties.
アルコールは特に限定されない。一例を挙げると、アルコールは、エタノール、イソプロパノール等の炭素数が2~3個の1価アルコール、プロピレングリコール、1,3-ブチレングリコール、ヘキシレングリコール、ジプロピレングリコール、グリセリン、ジグリセリンなどの多価アルコールである。 The alcohol is not particularly limited. For example, the alcohol may be a monohydric alcohol having 2 to 3 carbon atoms, such as ethanol or isopropanol, or a polyhydric alcohol, such as propylene glycol, 1,3-butylene glycol, hexylene glycol, dipropylene glycol, glycerin, or diglycerin.
アルコールが配合される場合、アルコールの含有量は特に限定されない。一例を挙げると、アルコールの含有量は、後発泡性組成物中、1質量%以上であることが好ましく、3質量%以上であることがより好ましい。また、アルコールの含有量は、後発泡性組成物中、30質量%以下であることが好ましく、25質量%以下であることがより好ましい。アルコールの含有量が上記範囲内であることにより、アルコールを配合することによる効果が得られやすく、かつ、後発泡性組成物は、アルコールによって発泡性が低下しにくい。 When alcohol is blended, the content of alcohol is not particularly limited. For example, the content of alcohol in the post-foamable composition is preferably 1% by mass or more, and more preferably 3% by mass or more. The content of alcohol in the post-foamable composition is preferably 30% by mass or less, and more preferably 25% by mass or less. By having the alcohol content within the above range, the effect of blending alcohol is easily obtained, and the foamability of the post-foamable composition is less likely to be reduced by the alcohol.
単糖類は、発泡性を調整する等の目的で好適に配合される。 Monosaccharides are preferably added for purposes such as adjusting the foaming properties.
単糖類は特に限定されない。一例を挙げると、単糖類は、ソルビトール、エリスリトール、アラビトール、ガラクチトール、グルシトール、マルチトール、マンニトール、キシリトールなどの糖アルコール;エリトリトール、D-エリトロース、D-トレオースなどのテトロース類;D-アラビノース、L-アラビノース、D-キシロース、D-リキソース、L-リキソース、D-リボース、D-キシルロース、L-キシルロース、D-リブロース、L-リブロースなどのペントース類;D-アルトロース、L-アルトロース、D-ガラクトース、L-ガラクトース、D-グルコース、D-タロース、D-マンノース、L-ソルボース、D-タガトース、D-プシコース、D-フルクトースなどのヘキソース類などである。 The monosaccharides are not particularly limited. Examples of monosaccharides include sugar alcohols such as sorbitol, erythritol, arabitol, galactitol, glucitol, maltitol, mannitol, and xylitol; tetroses such as erythritol, D-erythrose, and D-threose; pentoses such as D-arabinose, L-arabinose, D-xylose, D-lyxose, L-lyxose, D-ribose, D-xylulose, L-xylulose, D-ribulose, and L-ribulose; and hexoses such as D-altrose, L-altrose, D-galactose, L-galactose, D-glucose, D-talose, D-mannose, L-sorbose, D-tagatose, D-psicose, and D-fructose.
単糖類が配合される場合、単糖類の含有量は特に限定されない。一例を挙げると、単糖類の含有量は、後発泡性組成物中、0.5質量%以上であることが好ましく、1質量%以上であることがより好ましい。また、単糖類の含有量は、後発泡性組成物中、20質量%以下であることが好ましく、15質量%以下であることがより好ましい。単糖類の含有量が上記範囲内であることにより、単糖類を配合することによる効果が得られやすい。 When monosaccharides are blended, the content of the monosaccharides is not particularly limited. For example, the content of the monosaccharides in the post-foaming composition is preferably 0.5% by mass or more, and more preferably 1% by mass or more. The content of the monosaccharides in the post-foaming composition is preferably 20% by mass or less, and more preferably 15% by mass or less. When the content of the monosaccharides is within the above range, the effect of blending the monosaccharides is easily obtained.
水溶性高分子は、後発泡性組成物の発泡性を高くする目的や、フォームの保持力、硬さ、弾性、伸展性等を調整する等の目的で好適に配合される。 Water-soluble polymers are preferably blended to increase the foaming properties of the post-foamable composition and to adjust the foam retention, hardness, elasticity, extensibility, etc.
水溶性高分子は特に限定されない。一例を挙げると、水溶性高分子は、ジメチルジアリルアンモニウムクロリド(ポリクオタニウム4)、塩化ジメチルジアクリルアンモニウム・アクリルアミド共重合体(ポリオクタニウム7)、塩化-O-[2-ヒドロキシ-3-(トリメチルアンモニオ)プロピル]ヒドロキシエチルセルロース(ポリクオタニウム10)、塩化ジメチルジアリルアンモニウム・アクリル酸共重合体(ポリクオタニウム22)、塩化-O-[2-ヒドロキシ-3-(ラウリルジメチルアンモニオ)プロピル]ヒドロキシエチルセルロース(ポリオクタニウム24)、アクリルアミド・アクリル酸・塩化ジメチルジアリルアンモニウム共重合体(ポリクオタニウム39)、2-メタクリロイルオキシエチルホスホリルコリン・メタクリル酸ブチル共重合体液(ポリクオタニウム51)、N,N-ジメチルアミノエチルメタクリル酸ジエチル硫酸塩・N,N-ジメチルアクリルアミド・ジメタクリル酸ポリエチレングリコール(ポリクオタニウム52)、2-メタクリロイルオキシエチルホスホリルコリン・メタクリル酸ステアリル共重合体(ポリクオタニウム61)、メタクリロイルオキシエチレンホスホリルコリン、メタクリル酸ブチル及びメタクリル酸ナトリウム(ポリクオタニウム65)などのカチオン性ポリマー;セルロースナノファイバー、ヒドロキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロースナトリウムなどのセルロース系高分子;キサンタンガム、カラギーナン、アラビアゴム、トラガントゴム、カチオン化グアガム、グアガム、ジェランガムなどのガム質;デキストラン、カルボキシメチルデキストランナトリウム、デキストリン、ペクチン、アルギン酸ナトリウム、ヒアルロン酸ナトリウム、ポリビニルアルコール、カルボキシビニルポリマー等である。 The water-soluble polymer is not particularly limited. Examples of water-soluble polymers include dimethyl diallyl ammonium chloride (Polyquaternium 4), dimethyl diacryl ammonium chloride-acrylamide copolymer (Polyquaternium 7), chloride-O-[2-hydroxy-3-(trimethylammonio)propyl] hydroxyethyl cellulose (Polyquaternium 10), dimethyl diallyl ammonium chloride-acrylic acid copolymer (Polyquaternium 22), chloride-O-[2-hydroxy-3-(lauryldimethylammonio)propyl] hydroxyethyl cellulose (Polyquaternium 24), acrylamide-acrylic acid-dimethyl diallyl ammonium chloride copolymer (Polyquaternium 39), 2-methacryloyloxyethyl phosphorylcholine-butyl methacrylate copolymer liquid (Polyquaternium 51), N,N-dimethylaminoethyl diethyl methacrylate sulfate-N,N-dimethylacrylamide-dimethacrylate poly Cationic polymers such as ethylene glycol (polyquaternium 52), 2-methacryloyloxyethyl phosphorylcholine-stearyl methacrylate copolymer (polyquaternium 61), methacryloyloxyethylene phosphorylcholine, butyl methacrylate and sodium methacrylate (polyquaternium 65); cellulose-based polymers such as cellulose nanofiber, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose and sodium carboxymethylcellulose; gums such as xanthan gum, carrageenan, gum arabic, gum tragacanth, cationic guar gum, guar gum and gellan gum; dextran, sodium carboxymethyldextran, dextrin, pectin, sodium alginate, sodium hyaluronate, polyvinyl alcohol, carboxyvinyl polymer, etc.
水溶性高分子が配合される場合、水溶性高分子の含有量は特に限定されない。一例を挙げると、水溶性高分子の含有量は、後発泡性組成物中、0.01質量%以上であることが好ましく、0.05質量%以上であることがより好ましい。また、水溶性高分子の含有量は、後発泡性組成物中、5質量%以下であることが好ましく、3質量%以下であることがより好ましい。水溶性高分子の含有量が上記範囲内であることにより、水溶性高分子を配合することによる効果が得られやすく、かつ、後発泡性組成物の粘度が高くなり過ぎず、発泡性が低下しにくい。 When a water-soluble polymer is blended, the content of the water-soluble polymer is not particularly limited. For example, the content of the water-soluble polymer in the post-foamable composition is preferably 0.01% by mass or more, and more preferably 0.05% by mass or more. The content of the water-soluble polymer in the post-foamable composition is preferably 5% by mass or less, and more preferably 3% by mass or less. By having the content of the water-soluble polymer within the above range, the effect of blending the water-soluble polymer is easily obtained, and the viscosity of the post-foamable composition does not become too high, and the foamability is not easily reduced.
パウダーは、滑りを良くするなど、使用感を向上させるために好適に配合される。 Powder is ideally blended to improve the feel of the product, such as making it easier to slide on.
パウダーは特に限定されない。一例を挙げると、パウダーは、タルク、酸化亜鉛、酸化チタン、シリカ、ゼオライト、カオリン、雲母、炭酸マグネシウム、炭酸カルシウム、ケイ酸亜鉛、ケイ酸マグネシウム、ケイ酸アルミニウム、ケイ酸カルシウム等である。 The powder is not particularly limited. Examples of the powder include talc, zinc oxide, titanium oxide, silica, zeolite, kaolin, mica, magnesium carbonate, calcium carbonate, zinc silicate, magnesium silicate, aluminum silicate, calcium silicate, etc.
パウダーが配合される場合、パウダーの含有量は特に限定されない。一例を挙げると、パウダーの含有量は、後発泡性組成物中、0.1質量%以上であることが好ましく、0.3質量%以上であることがより好ましい。また、パウダーの含有量は、後発泡性組成物中、5質量%以下であることが好ましく、3質量%以下であることがより好ましい。パウダーの含有量が上記範囲内であることにより、パウダーを配合することによる効果が得られやすく、かつ、後発泡性組成物は、吐出される際に、吐出通路において詰まりを生じにくい。 When powder is blended, the powder content is not particularly limited. For example, the powder content in the post-foamable composition is preferably 0.1% by mass or more, and more preferably 0.3% by mass or more. The powder content in the post-foamable composition is preferably 5% by mass or less, and more preferably 3% by mass or less. By having the powder content within the above range, the effect of blending the powder is easily obtained, and the post-foamable composition is less likely to clog the discharge passage when it is discharged.
水性原液の調製方法は特に限定されない。水性原液は、従来公知の方法により調製することができる。たとえば、水性原液は、界面活性剤と、有効成分やアルコールなどの任意成分を水や温水に添加することで調製され得る。また、油剤を含有する場合は、水性原液を乳化物にしてもよい。 The method for preparing the aqueous concentrate is not particularly limited. The aqueous concentrate can be prepared by a conventional method. For example, the aqueous concentrate can be prepared by adding a surfactant and optional ingredients such as an active ingredient and alcohol to water or warm water. In addition, when an oil is contained, the aqueous concentrate may be made into an emulsion.
水性原液の含有量は、後発泡性組成物中、60質量%以上であることが好ましく、65質量%以上であることがより好ましい。また、水性原液の含有量は、後発泡性組成物中、95質量%以下であることが好ましく、90質量%以下であることがより好ましい。水性原液の含有量が上記範囲内であることにより、後発泡性組成物は、均一な乳化物を形成しやすくなり、ゲル状に吐出しやすくなる。 The content of the aqueous concentrate in the post-foamable composition is preferably 60% by mass or more, and more preferably 65% by mass or more. The content of the aqueous concentrate in the post-foamable composition is preferably 95% by mass or less, and more preferably 90% by mass or less. When the content of the aqueous concentrate is within the above range, the post-foamable composition is more likely to form a uniform emulsion and is more likely to be discharged in a gel form.
・沸点が5~25℃であるハイドロフルオロオレフィン
沸点が5~25℃であるハイドロフルオロオレフィンは、水性原液と乳化して後発泡性組成物を形成する。沸点が5~25℃であるハイドロフルオロオレフィンは、吐出容器から外部に吐出されると、気化して水性原液を発泡させる発泡剤として用いられる。
Hydrofluoroolefins having a boiling point of 5 to 25° C. Hydrofluoroolefins having a boiling point of 5 to 25° C. are emulsified with an aqueous concentrate to form a post-foamable composition. When discharged from a discharge container to the outside, the hydrofluoroolefins having a boiling point of 5 to 25° C. are vaporized and used as a foaming agent that foams the aqueous concentrate.
沸点が5~25℃であるハイドロフルオロオレフィンは、トランス-1-クロロ-3,3,3-トリフルオロプロペン(HFO-1233zd(E)、沸点19℃)であることが好ましい。沸点が5~25℃であるハイドロフルオロオレフィンが吐出時には気化が抑制されてゲル状となり、その後に徐々に気化して発泡することにより、得られるフォームは塗り伸ばしやすく、ハイドロフルオロオレフィンの気化熱により効率よく冷却されて冷たくなりやすい。 The hydrofluoroolefin having a boiling point of 5 to 25°C is preferably trans-1-chloro-3,3,3-trifluoropropene (HFO-1233zd(E), boiling point 19°C). When discharged, the hydrofluoroolefin having a boiling point of 5 to 25°C is inhibited from vaporizing and becomes gel-like, and then gradually vaporizes and foams, so that the resulting foam is easy to spread and can be efficiently cooled by the heat of vaporization of the hydrofluoroolefin, making it easy to become cold.
また、沸点が5~25℃のハイドロフルオロオレフィンの含有量は、後発泡性組成物中、3質量%以上であることが好ましく、5質量%以上であることがより好ましい。また、沸点が5~25℃のハイドロフルオロオレフィンの含有量は、後発泡性組成物中、30質量%以下であることが好ましく、25質量%以下であることがより好ましい。沸点が5~25℃のハイドロフルオロオレフィンの含有量が上記範囲内であることにより、後発泡性組成物は、より安定したゲル状に吐出されやすく、吐出後に徐々に発泡し、適度な冷却感が得られやすい。 The content of the hydrofluoroolefin having a boiling point of 5 to 25°C in the post-foamable composition is preferably 3% by mass or more, and more preferably 5% by mass or more. The content of the hydrofluoroolefin having a boiling point of 5 to 25°C in the post-foamable composition is preferably 30% by mass or less, and more preferably 25% by mass or less. By having the content of the hydrofluoroolefin having a boiling point of 5 to 25°C within the above range, the post-foamable composition is more likely to be discharged in a more stable gel-like form, gradually foams after being discharged, and an appropriate cooling sensation is more likely to be obtained.
本実施形態の後発泡性組成物は、発泡剤として、沸点が5~25℃のハイドロフルオロオレフィン以外に他の低沸点溶剤が併用されてもよい。このような低沸点溶剤としては、たとえば、トランス-1,3,3,3-テトラフルオロプロパ-1-エン(HFO-1234ze、沸点-19℃)、トランス-2,3,3,3-テトラフルオロプロパ-1-エン(HFO-1234yf、沸点-29℃)などの沸点が5℃未満のハイドロフルオロオレフィン、シス-1-クロロ-3,3,3-トリフルオロプロペン(HFO-1233zd(Z)、沸点39℃)などの沸点が25℃を超えるハイドロフルオロオレフィン、プロパン、ノルマルブタン、イソブタン、イソペンタンおよびこれらの混合物からなる炭素数3~5個の脂肪族炭化水素、ジメチルエーテル、およびこれらの混合物等の液化ガス等である。 In the post-foamable composition of this embodiment, other low-boiling point solvents may be used in combination as a foaming agent in addition to hydrofluoroolefins having a boiling point of 5 to 25°C. Examples of such low-boiling point solvents include hydrofluoroolefins having a boiling point of less than 5°C, such as trans-1,3,3,3-tetrafluoroprop-1-ene (HFO-1234ze, boiling point -19°C) and trans-2,3,3,3-tetrafluoroprop-1-ene (HFO-1234yf, boiling point -29°C), hydrofluoroolefins having a boiling point of more than 25°C, such as cis-1-chloro-3,3,3-trifluoropropene (HFO-1233zd(Z), boiling point 39°C), aliphatic hydrocarbons having 3 to 5 carbon atoms, such as propane, normal butane, isobutane, isopentane, and mixtures thereof, dimethyl ether, and liquefied gases such as mixtures thereof.
低沸点溶剤が配合される場合、低沸点溶剤の含有量は特に限定されない。一例を挙げると、低沸点溶剤の含有量は、後発泡性組成物中、0.5質量%以上であることが好ましく、1質量%以上であることがより好ましい。また、低沸点溶剤の含有量は、後発泡性組成物中、5質量%以下であることが好ましく、3質量%以下であることがより好ましい。低沸点溶剤の含有量が上記範囲内であることにより、後発泡性組成物は、発泡状態を調整しやすい。 When a low-boiling solvent is blended, the content of the low-boiling solvent is not particularly limited. As an example, the content of the low-boiling solvent in the post-foamable composition is preferably 0.5% by mass or more, and more preferably 1% by mass or more. The content of the low-boiling solvent in the post-foamable composition is preferably 5% by mass or less, and more preferably 3% by mass or less. By having the content of the low-boiling solvent within the above range, the foaming state of the post-foamable composition can be easily adjusted.
(圧縮ガス)
圧縮ガスは、後発泡性組成物を吐出するための加圧剤として配合されてもよい。圧縮ガスは特に限定されない。一例を挙げると、圧縮ガスは、窒素、空気、酸素、水素、二酸化炭素、亜酸化窒素等である。
(Compressed Gas)
The compressed gas may be blended as a pressurizing agent for discharging the post-foamable composition. The compressed gas is not particularly limited. Examples of the compressed gas include nitrogen, air, oxygen, hydrogen, carbon dioxide, and nitrous oxide.
圧縮ガスが使用される場合、圧縮ガスは、25℃における吐出容器内の圧力が0.2MPa以上となるよう充填されることが好ましく、0.3MPa以上となるよう充填されることがより好ましい。また、圧縮ガスは、25℃における吐出容器内の圧力が0.8MPa以下となるよう充填されることが好ましく、0.7MPa以下となるよう充填されることがより好ましい。圧力が上記範囲内になるよう圧縮ガスが充填されることにより、ハイドロフルオロオレフィンは、吐出容器内においても水性原液との均一な乳化状態が維持されやすい。そのため、後発泡性組成物は、ゲル状に吐出されやすい。 When compressed gas is used, the compressed gas is preferably filled so that the pressure inside the discharge container at 25°C is 0.2 MPa or more, and more preferably 0.3 MPa or more. The compressed gas is preferably filled so that the pressure inside the discharge container at 25°C is 0.8 MPa or less, and more preferably 0.7 MPa or less. By filling the compressed gas so that the pressure is within the above range, the hydrofluoroolefin is likely to maintain a uniform emulsified state with the aqueous concentrate even inside the discharge container. Therefore, the post-foamable composition is likely to be discharged in a gel-like form.
次に、上記水性原液および発泡剤を含む後発泡性組成物の製造方法について説明する。後発泡性組成物の製造方法は、発泡剤中に溶解している空気を25℃における飽和溶解量以下に減らす脱気工程と、脱気した発泡剤と水性原液とを混合して乳化する乳化工程と、得られた乳化物を吐出容器に充填する充填工程と、を有する。 Next, a method for producing a post-foamable composition containing the aqueous concentrate and a foaming agent will be described. The method for producing a post-foamable composition includes a degassing step for reducing the amount of air dissolved in the foaming agent to the saturated solubility amount or less at 25°C, an emulsification step for mixing the degassed foaming agent with the aqueous concentrate to emulsify, and a filling step for filling the obtained emulsion into a discharge container.
(脱気工程)
脱気工程は、発泡剤中に溶解している空気を25℃における飽和溶解量以下に減らす工程である。脱気工程において、発泡剤中に溶解している空気を25℃における飽和溶解量以下に減らすための具体的方法は特に限定されない。一例を挙げると、脱気工程は、発泡剤(ハイドロフルオロオレフィン)を加温する工程(加温工程)、ハイドロフルオロオレフィンを貯蔵しているタンク内を減圧する工程(減圧工程)、ハイドロフルオロオレフィンを超音波処理する工程(超音波処理工程)、などの工程を採用することにより実施され得る。以下、一例として、加温工程を採用する場合を例示する。
(Degassing process)
The degassing process is a process for reducing the amount of air dissolved in the foaming agent to the saturated solubility or less at 25° C. In the degassing process, the specific method for reducing the amount of air dissolved in the foaming agent to the saturated solubility or less at 25° C. in the degassing process is not particularly limited. As an example, the degassing process can be carried out by adopting a process such as a process of heating the foaming agent (hydrofluoroolefin) (heating process), a process of reducing the pressure inside a tank storing the hydrofluoroolefin (pressure reduction process), and a process of ultrasonically treating the hydrofluoroolefin (ultrasonic treatment process). Hereinafter, as an example, a case where a heating process is adopted will be illustrated.
(加温工程)
加温工程は、発泡剤を沸点以上に加温する工程であり、脱気工程において好適に実施される。加温工程は、たとえば、ハイドロフルオロオレフィンを含む発泡剤をタンクなどの貯蔵容器に充填してハイドロフルオロオレフィンの沸点以上に加温する、または、貯蔵容器から乳化機に連結される配管内でハイドロフルオロオレフィンの沸点以上に加温する、等の方法により実施され得る。これにより、ハイドロフルオロオレフィンに溶解している空気が脱気されて除去される。
(Heating process)
The heating step is a step of heating the blowing agent to above its boiling point, and is preferably carried out in the degassing step. The heating step can be carried out, for example, by filling a blowing agent containing hydrofluoroolefin in a storage container such as a tank and heating it to above the boiling point of the hydrofluoroolefin, or by heating it to above the boiling point of the hydrofluoroolefin in a pipe connected from the storage container to the emulsifier. This allows the air dissolved in the hydrofluoroolefin to be degassed and removed.
なお、ハイドロフルオロオレフィンに溶解している空気を脱気して除去する理由は、以下のとおりである。すなわち、ハイドロフルオロオレフィンは、空気等の圧縮ガスの溶解量が多い。そのため、空気が多く溶解したハイドロフルオロオレフィンは、外部に吐出されると、溶解していた空気が気化・膨張し、これが起点となってハイドロフルオロオレフィンの気化も促進され、吐出物が泡立ち易くなる。そのため、従来、ハイドロフルオロオレフィンを含む吐出物を、ゲル状に吐出し、その後、剪断等によって後発泡させることは不可能であった。しかしながら、本実施形態では、このような脱気工程(加温工程)を採用することにより、ハイドロフルオロオレフィンを沸点以上に加温して、空気の溶解量を減らしている。その結果、ハイドロフルオロオレフィンは、外部に吐出されても、溶解していた空気が脱気しない場合と比較して少ないため、気化が促進されにくい。その結果、本実施形態の製造方法により作製された後発泡性組成物は、吐出時の泡立ちが抑制されて、ゲル状に吐出することができる。 The reason for removing the air dissolved in the hydrofluoroolefin by degassing is as follows. That is, hydrofluoroolefin dissolves a large amount of compressed gas such as air. Therefore, when hydrofluoroolefin with a large amount of dissolved air is discharged to the outside, the dissolved air vaporizes and expands, which starts to promote the vaporization of the hydrofluoroolefin, making the discharged product more likely to foam. Therefore, in the past, it was impossible to discharge a discharged product containing hydrofluoroolefin in a gel state and then post-foam it by shearing or the like. However, in this embodiment, by adopting such a degassing process (warming process), the hydrofluoroolefin is heated to a temperature above the boiling point, thereby reducing the amount of dissolved air. As a result, even if the hydrofluoroolefin is discharged to the outside, the amount of dissolved air is less than that in the case where degassing is not performed, and vaporization is less likely to be promoted. As a result, the post-foamable composition produced by the manufacturing method of this embodiment can be discharged in a gel state with suppressed foaming during discharge.
また、加温工程が採用されていることにより、本実施形態の製造方法は、発泡剤中に溶解している空気の溶解量を調整しやすい。また、水性原液と発泡剤との混合物は、後述する乳化工程においてゆっくりと粘度が上昇する。そのため、水性原液と発泡剤とは、均一に混合されやすい。その結果、得られる後発泡性組成物は、安定して吐出されやすい。 In addition, by adopting a heating process, the manufacturing method of this embodiment makes it easy to adjust the amount of air dissolved in the foaming agent. In addition, the viscosity of the mixture of the aqueous concentrate and the foaming agent increases slowly in the emulsification process described below. Therefore, the aqueous concentrate and the foaming agent are easily mixed uniformly. As a result, the resulting post-foamable composition is easily discharged stably.
加温工程は、発泡剤を収容している容器(貯蔵容器)内や、配管内の気体を外部に排出する排出工程を含んでもよい。このような排出工程が実施されることにより、発泡剤に溶解していた空気は、外部に排出されやすい。これにより、発泡剤への空気の再溶解を防ぐことができる。その結果、得られる後発泡性組成物は、吐出時の発泡を抑制しやすく、ゲル状に吐出されやすい。なお、排出工程は、公知のベント機構等によって実施され得る。 The heating step may include a discharge step of discharging gas from the container (storage container) containing the foaming agent or from the piping to the outside. By carrying out such a discharge step, the air dissolved in the foaming agent is easily discharged to the outside. This makes it possible to prevent the air from redissolving in the foaming agent. As a result, the resulting post-foamable composition is easily suppressed from foaming during discharge and is easily discharged in a gel state. The discharge step may be carried out by a known vent mechanism or the like.
(乳化工程)
乳化工程は、脱気した発泡剤と水性原液とを混合して乳化する工程である。乳化工程は、たとえば、加温されたハイドロフルオロオレフィンと水性原液とが、それぞれバッチ式乳化機や連続式乳化機に送られて混合されることにより実施され得る。
(Emulsification process)
The emulsification step is a step of mixing and emulsifying the degassed foaming agent and the aqueous concentrate. The emulsification step can be carried out, for example, by sending the heated hydrofluoroolefin and the aqueous concentrate to a batch emulsifier or a continuous emulsifier, respectively, and mixing them.
なお、脱気工程において加温工程が採用される場合、水性原液もハイドロフルオロオレフィンの沸点以上に加温されることが好ましい。これにより、水性原液とハイドロフルオロオレフィンとの混合物は、ゆっくりと粘度上昇し得るため、均一に混合されやすい。その結果、得られる後発泡性組成物は、安定して吐出されやすい。 When a heating step is employed in the degassing step, it is preferable that the aqueous concentrate is also heated to a temperature equal to or higher than the boiling point of the hydrofluoroolefin. This allows the viscosity of the mixture of the aqueous concentrate and the hydrofluoroolefin to increase slowly, making it easier to mix uniformly. As a result, the resulting post-foamable composition is easier to discharge stably.
特に、水性原液とハイドロフルオロオレフィンとは、30~80℃の条件下で乳化されることが好ましく、35~70℃の条件下で乳化されることがより好ましい。これにより、乳化工程において、水性原液と発泡剤との混合物の粘度がより上昇しにくい。そのため、混合物の温度を維持しやすく、吐出容器に充填しやすい。充填された混合物(後発泡性組成物)は、その後、吐出容器内で粘度上昇しやすい。 In particular, the aqueous concentrate and the hydrofluoroolefin are preferably emulsified under conditions of 30 to 80°C, and more preferably under conditions of 35 to 70°C. This makes it more difficult for the viscosity of the mixture of the aqueous concentrate and the foaming agent to increase during the emulsification process. This makes it easier to maintain the temperature of the mixture, and to fill it into the discharge container. The filled mixture (post-foamable composition) is then more likely to increase in viscosity within the discharge container.
(充填工程)
充填工程は、得られた乳化物を吐出容器に充填する工程である。これにより、後発泡性組成物を充填した吐出製品が得られる。
(Filling process)
The filling step is a step of filling the obtained emulsion into a discharge container, thereby obtaining a discharged product filled with the post-foamable composition.
吐出容器は特に限定されない。一例を挙げると、吐出容器は、開口部を有する容器本体と、開口部を密封するバルブと、バルブを吐出操作する吐出部材とからなる。 The discharge container is not particularly limited. As an example, the discharge container is composed of a container body having an opening, a valve that seals the opening, and a discharge member that operates the valve to discharge.
容器本体は、後発泡性組成物が充填される耐圧容器である。容器本体は、1つの容器であってもよく、外部容器と、外部容器内に収容される可撓性を有する内部容器とからなる二重容器であってもよい。 The container body is a pressure-resistant container in which the post-foamable composition is filled. The container body may be a single container, or may be a double container consisting of an outer container and a flexible inner container housed within the outer container.
1つの容器や外部容器の材質は特に限定されない。一例を挙げると、材質は、アルミニウム、ブリキ等の金属、各種合成樹脂、耐圧ガラス等である。内部容器は特に限定されない。一例を挙げると、内部容器は、ポリエチレン、ポリエチレンテレフタレート、エバール、ナイロンなどの合成樹脂を単層または多層の袋状にブロー成形した内袋、ポリエチレン、ポリエチレンテレフタレート、アルミニウムなどのシートを貼り合わせ、製造したパウチなど可撓性を有する容器等である。ハイドロフルオロオレフィンは圧縮ガスが溶解することにより発泡しやすくなる。そのため、内部容器は、エバールやナイロンなどのガスバリア性を有する合成樹脂を用いた多層の内袋やアルミニウムなどの軽金属のシートを用いた積層状のパウチであることが好ましい。 The material of one container or the outer container is not particularly limited. For example, the material may be metal such as aluminum or tinplate, various synthetic resins, pressure-resistant glass, etc. The inner container is not particularly limited. For example, the inner container may be a flexible container such as an inner bag made by blow-molding synthetic resin such as polyethylene, polyethylene terephthalate, EVAL, or nylon into a single-layer or multi-layer bag shape, or a pouch made by bonding together sheets of polyethylene, polyethylene terephthalate, aluminum, etc. Hydrofluoroolefins tend to foam when compressed gas dissolves in them. Therefore, it is preferable that the inner container is a multi-layer inner bag made of synthetic resin with gas barrier properties such as EVAL or nylon, or a laminated pouch made of a sheet of light metal such as aluminum.
バルブは、容器本体の開口を閉止して密封するための部材である。また、バルブは、ハウジングと、容器本体の内外を連通するステム孔が形成されたステムと、ステム孔の周囲に取り付けられ、ステム孔を閉止するためのステムラバーとを主に備える。ハウジングは、ステムを収容する。ステムは、略円筒状の部位であり、吐出時にハウジング内に取り込まれた後発泡性組成物が通過するステム内通路が形成されている。ステム内通路の下端近傍には、ハウジング内の空間とステム内通路とを連通するステム孔が形成されている。ステムの上端には、後発泡性組成物を吐出するための吐出部材が取り付けられる。ステムラバーは、ステム孔の周囲に取り付けられ、ハウジングの内部空間と外部とを適宜遮断するための部材である。ステムラバーは、円盤状の部材であり、非吐出時において、内周面をステムのステム孔が形成された外周面と密着させて、ステム孔を閉止する。 The valve is a member for closing and sealing the opening of the container body. The valve mainly comprises a housing, a stem with a stem hole formed therein that communicates between the inside and outside of the container body, and a stem rubber attached around the stem hole to close the stem hole. The housing accommodates the stem. The stem is a substantially cylindrical part, and an internal stem passage is formed through which the post-foamable composition taken into the housing during discharge passes. A stem hole is formed near the lower end of the internal stem passage that communicates the space inside the housing with the internal stem passage. A discharge member for discharging the post-foamable composition is attached to the upper end of the stem. The stem rubber is a member attached around the stem hole to appropriately block the internal space of the housing from the outside. The stem rubber is a disc-shaped member, and when not being discharged, the inner peripheral surface of the stem is in close contact with the outer peripheral surface of the stem in which the stem hole is formed, to close the stem hole.
吐出部材は、バルブの開閉を操作して後発泡性組成物を吐出するための部材であり、ステムの上端に取り付けられる。吐出部材は、ノズル部と、使用者が指等により操作する操作部とを主に備える。ノズル部は、略円筒状の部位であり、後発泡性組成物が通過する吐出通路が形成されている。吐出通路の先端には開口(吐出孔)が形成されている。吐出孔からは、後発泡性組成物が吐出される。吐出孔の数および形状は特に限定されない。吐出孔は、複数であってもよい。また、吐出孔の形状は、略円形状、略角形状等であってもよい。 The discharge member is a member for discharging the post-foamable composition by opening and closing the valve, and is attached to the upper end of the stem. The discharge member mainly comprises a nozzle portion and an operating portion that is operated by the user with a finger or the like. The nozzle portion is a substantially cylindrical portion, and has a discharge passage through which the post-foamable composition passes. An opening (discharge hole) is formed at the tip of the discharge passage. The post-foamable composition is discharged from the discharge hole. The number and shape of the discharge holes are not particularly limited. There may be multiple discharge holes. The shape of the discharge hole may also be substantially circular, substantially angular, etc.
本実施形態の吐出製品は、吐出部材が押し下げられると、バルブのステムが下方に押し下げられる。これにより、ステムラバーが下方に撓み、ステム孔が開放される。その結果、容器本体(内部容器)内と外部とが連通する。容器本体内と外部とが連通すると、容器本体内の圧力と外部との圧力差によって、後発泡性組成物がハウジング内に取り込まれ、次いで、ステム孔、ステム内通路を通過し、吐出部材に送られ、その後、吐出孔から吐出される。 In the discharge product of this embodiment, when the discharge member is pressed down, the stem of the valve is pressed down. This causes the stem rubber to bend downward and the stem hole to open. As a result, the inside of the container body (inner container) is connected to the outside. When the inside of the container body is connected to the outside, the post-foamable composition is taken into the housing by the pressure difference between the pressure inside the container body and the outside, then passes through the stem hole and the stem internal passage, is sent to the discharge member, and is then discharged from the discharge hole.
以上、本実施形態の後発泡性組成物の製造方法によれば、脱気工程によって、沸点が5~25℃であるハイドロフルオロオレフィンに溶解していた圧縮ガス(空気)が脱気される。その結果、吐出された後発泡性組成物は、溶解していた空気を起点とする発泡が抑制されやすい。したがって、後発泡性組成物は、ゲル状に吐出され得る。ゲル状に吐出された後発泡性組成物は、指などで剪断を加えることによって容易に発泡させることができる。 As described above, according to the method for producing the post-foamable composition of this embodiment, the compressed gas (air) dissolved in the hydrofluoroolefin having a boiling point of 5 to 25°C is degassed by the degassing step. As a result, foaming originating from the dissolved air is easily suppressed in the discharged post-foamable composition. Therefore, the post-foamable composition can be discharged in a gel state. The post-foamable composition discharged in a gel state can be easily foamed by applying shear with a finger or the like.
以下、実施例により本発明をより具体的に説明する。本発明は、これら実施例に何ら限定されない。 The present invention will be described in more detail below with reference to examples. The present invention is not limited to these examples.
(実施例1)
以下の処方(単位:質量%)に従って、水性原液を乳化タンク内で調製し、水性原液を50℃に加温調整した。発泡剤として沸点が19℃であるハイドロフルオロオレフィン(トランス-1-クロロ-3,3,3-トリフルオロプロペン、HFO-1233zd(E))を用い、気密タンクに充填して、50℃に加温調整した。気密タンクのベント機構により気相部を外部に排出してハイドロフルオロオレフィンに溶解している空気濃度を下げた(加温工程、脱気工程)。ハイドロフルオロオレフィンの含有量が後発泡性組成物中20質量%になるように乳化タンクに注入し、水性原液と混合し、乳化させた(乳化工程)。多層構造のパウチ(ポリエチレン/アルミ/ポリエチレン)を備えているバルブと容器本体を用いて、容器本体とパウチとの間を窒素で加圧し、バルブを固定して密閉した二重容器を準備した。乳化タンクから乳化物(後発泡性組成物)を、バルブのステムからパウチに充填した(充填工程)。吐出容器内の圧力は、0.7MPa(25℃)であった。
Example 1
According to the following recipe (unit: mass %), an aqueous stock solution was prepared in an emulsification tank, and the aqueous stock solution was heated and adjusted to 50°C. Hydrofluoroolefin (trans-1-chloro-3,3,3-trifluoropropene, HFO-1233zd(E)) with a boiling point of 19°C was used as a foaming agent, and the foaming agent was filled into an airtight tank and heated and adjusted to 50°C. The gas phase was discharged to the outside by the vent mechanism of the airtight tank to reduce the concentration of air dissolved in the hydrofluoroolefin (heating step, degassing step). The hydrofluoroolefin was injected into the emulsification tank so that the content of the post-foamable composition was 20% by mass, mixed with the aqueous stock solution, and emulsified (emulsification step). A valve and a container body equipped with a multi-layered pouch (polyethylene/aluminum/polyethylene) were used to pressurize the space between the container body and the pouch with nitrogen, and a double container was prepared by fixing the valve and sealing it. The emulsion (post-foamable composition) was filled from the emulsification tank into the pouch from the stem of the valve (filling step). The pressure inside the discharge vessel was 0.7 MPa (25° C.).
<水性原液>
流動パラフィン(*1) 2.0
パラフィン(*2) 2.0
精製水 61.9
オレス-20(*3) 2.0
コカミドDEA(*4) 5.0
パルミチン酸(*5) 6.8
ミリスチン酸(*6) 1.0
グリセリン(*7) 10.0
ソルビトール/水(*8) 5.0
メチルパラベン(*9) 0.1
トリエタノールアミン(*10) 4.2
合計 100.0(質量%)
*1:ハイコールK-350(商品名)、カネダ(株)製
*2:Paraffin Wax-125(商品名)、日本精蝋(株)製
*3:BO-20V(商品名)、日光ケミカルズ(株)製
*4:アミゾール CDE(商品名)、川研ファインケミカル(株)製
*5:ルナックP-95(商品名)、花王(株)製
*6:ルナックMY-98(商品名)、花王(株)製
*7:濃グリセリン(商品名)、花王(株)製
*8:ソルビトール花王(商品名)、花王(株)製
*9:メッキンスM(商品名)、上野製薬(株)製
*10:トリエタノールアミン-S(商品名)、(株)日本触媒製
<Aqueous concentrate>
Liquid paraffin (*1) 2.0
Paraffin (*2) 2.0
Purified water 61.9
Oleth-20 (*3) 2.0
Cocamide DEA (*4) 5.0
Palmitic acid (*5) 6.8
Myristic acid (*6) 1.0
Glycerin (*7) 10.0
Sorbitol/water (*8) 5.0
Methylparaben (*9) 0.1
Triethanolamine (*10) 4.2
Total 100.0 (mass%)
*1: Hicol K-350 (trade name), manufactured by Kaneda Co., Ltd. *2: Paraffin Wax-125 (trade name), manufactured by Nippon Seiro Co., Ltd. *3: BO-20V (trade name), manufactured by Nikko Chemicals Co., Ltd. *4: Amizol CDE (trade name), manufactured by Kawaken Fine Chemical Co., Ltd. *5: Lunac P-95 (trade name), manufactured by Kao Corporation *6: Lunac MY-98 (trade name), manufactured by Kao Corporation *7: Concentrated Glycerin (trade name), manufactured by Kao Corporation *8: Sorbitol Kao (trade name), manufactured by Kao Corporation *9: Mekkins M (trade name), manufactured by Ueno Pharmaceutical Co., Ltd. *10: Triethanolamine-S (trade name), manufactured by Nippon Shokubai Co., Ltd.
(実施例2)
ハイドロフルオロオレフィンの温度を40℃に加温調整し、水性原液の温度を40℃に加温調整して製造したこと以外は、実施例1と同様にして後発泡性組成物を充填し、吐出製品を作製した。
Example 2
The temperature of the hydrofluoroolefin was adjusted by heating to 40°C, and the temperature of the aqueous concentrate was adjusted by heating to 40°C. In the same manner as in Example 1, except that the temperature was adjusted by heating to 40°C, the post-foamable composition was filled and a discharged product was produced.
(実施例3)
ハイドロフルオロオレフィンの温度を30℃に加温調整し、水性原液の温度を30℃に加温調整して製造したこと以外は、実施例1と同様にして後発泡性組成物を充填し、吐出製品を作製した。
Example 3
The temperature of the hydrofluoroolefin was adjusted by heating to 30°C, and the temperature of the aqueous concentrate was adjusted by heating to 30°C. In the same manner as in Example 1, except that the temperature of the hydrofluoroolefin was adjusted by heating to 30°C, the post-foamable composition was filled and a discharged product was produced.
(実施例4)
ハイドロフルオロオレフィンの温度を60℃に加温調整し、水性原液の温度を60℃に加温調整して製造したこと以外は、実施例1と同様にして後発泡性組成物を充填し、吐出製品を作製した。
Example 4
The temperature of the hydrofluoroolefin was adjusted by heating to 60°C, and the temperature of the aqueous concentrate was adjusted by heating to 60°C. In the same manner as in Example 1, except that the temperature of the hydrofluoroolefin was adjusted by heating to 60°C, the post-foamable composition was filled and a discharged product was produced.
(実施例5)
ハイドロフルオロオレフィンの温度を50℃に加温調整し、水性原液の温度を25℃に加温調整して製造したこと以外は、実施例1と同様にして後発泡性組成物を充填し、吐出製品を作製した。
Example 5
The post-foamable composition was filled and a discharged product was prepared in the same manner as in Example 1, except that the temperature of the hydrofluoroolefin was adjusted to 50°C and the temperature of the aqueous concentrate was adjusted to 25°C.
(比較例1)
ハイドロフルオロオレフィンの温度を15℃に冷却調整し、水性原液の温度を15℃に冷却調整して製造したこと以外は、実施例1と同様にして後発泡性組成物を充填し、吐出製品を作製した。
(Comparative Example 1)
The temperature of the hydrofluoroolefin was cooled and adjusted to 15°C, and the temperature of the aqueous concentrate was cooled and adjusted to 15°C. Except for this, the post-foamable composition was filled in the same manner as in Example 1 to prepare a discharged product.
実施例1~5および比較例1において調製した吐出製品を用いて、以下の評価方法により、後発泡性組成物の吐出状態、せん断を加えたときの発泡状態を評価した。結果を表1に示す。 Using the discharged products prepared in Examples 1 to 5 and Comparative Example 1, the discharged state of the post-foamable composition and the foaming state when shear was applied were evaluated by the following evaluation methods. The results are shown in Table 1.
<吐出時の吐出物の状態>
吐出製品を25℃に調整された恒温水槽中に1時間浸漬し、後発泡性組成物を25℃に調整した。恒温水槽から吐出製品を取り出し、手のひら上に1g吐出した。吐出時の後発泡性組成物の状態を以下の評価基準に従って評価した。
(評価基準)
◎:後発泡性組成物は、透明なゲル状で吐出された。
○:後発泡性組成物は、わずかに濁っていたがゲル状で吐出された。
×:後発泡性組成物は、一部が発泡したゲル状で吐出された。
<State of the material when discharged>
The discharged product was immersed in a thermostatic water bath adjusted to 25° C. for 1 hour, and the post-foamable composition was adjusted to 25° C. The discharged product was removed from the thermostatic water bath, and 1 g of the product was discharged onto the palm of a hand. The state of the post-foamable composition upon discharge was evaluated according to the following evaluation criteria.
(Evaluation criteria)
⊚: The post-foamable composition was discharged in the form of a transparent gel.
◯: The post-foamable composition was slightly cloudy but discharged in a gel state.
×: The post-foamable composition was discharged in a partially foamed gel state.
<せん断後の吐出物の状態>
手のひらに吐出された後発泡性組成物を指でかき混ぜた。かき混ぜた後発泡性組成物の状態を以下の評価基準に従って評価した。
(評価基準)
◎:後発泡性組成物は、ゆっくり発泡して均一できめ細かい粒の泡になった。
○:後発泡性組成物は、ゆっくり発泡してきめ細かい粒の泡になった。
×:後発泡性組成物は、ゆっくり発泡したが泡の粒の大きさにムラができた。
<State of extruded material after shearing>
After being dispensed onto the palm of the hand, the foamable composition was stirred with the fingers. After stirring, the state of the foamable composition was evaluated according to the following evaluation criteria.
(Evaluation criteria)
⊚: The post-foamable composition foamed slowly to form a uniform, finely grained foam.
◯: The post-foamable composition foamed slowly to form finely granular foam.
×: The post-foamable composition foamed slowly, but the size of the bubbles was uneven.
表1に示されるように、実施例1~5の製造方法により得られた後発泡性組成物は、透明なゲル状に吐出され、指でかき混ぜることにより、ゆっくりと発泡させることができ、きめ細かい粒の泡が得られた。一方、加温工程(脱気工程)を実施しなかった比較例1の製造方法により得られた後発泡性組成物は、吐出時に発泡し、指でかき混ぜることにより、ゆっくりと発泡したが、泡の粒の大きさにムラがあった。 As shown in Table 1, the post-foamable compositions obtained by the manufacturing methods of Examples 1 to 5 were discharged in a transparent gel form and could be slowly foamed by stirring with fingers, resulting in finely granular foam. On the other hand, the post-foamable composition obtained by the manufacturing method of Comparative Example 1, in which the heating step (degassing step) was not performed, foamed when discharged and slowly foamed by stirring with fingers, but the size of the bubbles was uneven.
Claims (5)
前記発泡剤中に溶解している空気を25℃における飽和溶解量以下に減らす脱気工程と、
脱気した前記発泡剤と前記水性原液とを混合して乳化する乳化工程と、
得られた乳化物を吐出容器に充填する充填工程と、を有する、後発泡性組成物の製造方法。 A method for producing a post-foamable composition, comprising: an aqueous concentrate containing water and a surfactant; and a foaming agent containing a hydrofluoroolefin having a boiling point of 5 to 25°C,
a degassing step of reducing the amount of air dissolved in the foaming agent to a saturated solubility amount at 25°C or less;
an emulsification step of mixing the degassed foaming agent and the aqueous concentrate to emulsify;
and filling the obtained emulsion into a discharge container.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020125487A JP7498049B2 (en) | 2020-07-22 | 2020-07-22 | Method for producing post-foamable composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020125487A JP7498049B2 (en) | 2020-07-22 | 2020-07-22 | Method for producing post-foamable composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022021718A JP2022021718A (en) | 2022-02-03 |
JP7498049B2 true JP7498049B2 (en) | 2024-06-11 |
Family
ID=80220622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020125487A Active JP7498049B2 (en) | 2020-07-22 | 2020-07-22 | Method for producing post-foamable composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7498049B2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4934912B2 (en) | 2001-06-06 | 2012-05-23 | 三菱化学株式会社 | Electrolyte and secondary battery |
CN109464300A (en) | 2018-12-28 | 2019-03-15 | 中山市天图精细化工有限公司 | Foam mildy wash and preparation method thereof after one kind |
JP2020183361A (en) | 2019-05-09 | 2020-11-12 | 株式会社ダイゾー | Post-foamable composition |
-
2020
- 2020-07-22 JP JP2020125487A patent/JP7498049B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4934912B2 (en) | 2001-06-06 | 2012-05-23 | 三菱化学株式会社 | Electrolyte and secondary battery |
CN109464300A (en) | 2018-12-28 | 2019-03-15 | 中山市天图精细化工有限公司 | Foam mildy wash and preparation method thereof after one kind |
JP2020183361A (en) | 2019-05-09 | 2020-11-12 | 株式会社ダイゾー | Post-foamable composition |
Also Published As
Publication number | Publication date |
---|---|
JP2022021718A (en) | 2022-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6204535B2 (en) | Aerosol composition | |
JP6282848B2 (en) | Foamable coating composition | |
WO2011155630A1 (en) | Aerosol composition | |
JP7368120B2 (en) | aerosol products | |
JP5283389B2 (en) | Aerosol composition | |
JP2009120525A (en) | Aerosol product and method for discharging | |
JP4971713B2 (en) | Aerosol composition and aerosol product comprising the aerosol composition | |
JP7498049B2 (en) | Method for producing post-foamable composition | |
JP5714408B2 (en) | Aerosol composition | |
JP7294873B2 (en) | Post-foaming composition | |
JP6571401B2 (en) | Aerosol products | |
JP5180601B2 (en) | Aerosol composition | |
JP2006265137A (en) | Emulsion aerosol composition | |
JP2003081763A (en) | Aerosol composition and foamable aerosol product | |
JP5276781B2 (en) | Aerosol composition | |
JP2021017440A (en) | Post-foamable composition | |
JP5781724B2 (en) | Aerosol products | |
JP6823383B2 (en) | Two-component aerosol product | |
JP7325973B2 (en) | Effervescent aerosol composition | |
JP7108502B2 (en) | Effervescent composition | |
JP2022180104A (en) | Foamable composition, filling container and discharge product | |
JP2020023474A (en) | Foamable composition | |
JP6794130B2 (en) | Two-component foamed aerosol composition | |
JP7261058B2 (en) | Effervescent aerosol composition | |
WO2022191203A1 (en) | Aerosol raw material composition, aerosol composition, and aerosol product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230703 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240515 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240528 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240530 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7498049 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |